Agenus to participate at william blair's biotech focus conference

Lexington, mass., june 30, 2022 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced that dr. steven o'day, chief medical officer, will participate in a panel discussion on developing therapies for the next immuno-oncology targets at william blair's biotech focus conference on tuesday, july 12, 2022, at 4:10 pm est.
AGEN Ratings Summary
AGEN Quant Ranking